MX2012012712A - A pharmaceutical composition for use in treating or preventing either one or both of an inflammatory disease and an autoimmune disease. - Google Patents

A pharmaceutical composition for use in treating or preventing either one or both of an inflammatory disease and an autoimmune disease.

Info

Publication number
MX2012012712A
MX2012012712A MX2012012712A MX2012012712A MX2012012712A MX 2012012712 A MX2012012712 A MX 2012012712A MX 2012012712 A MX2012012712 A MX 2012012712A MX 2012012712 A MX2012012712 A MX 2012012712A MX 2012012712 A MX2012012712 A MX 2012012712A
Authority
MX
Mexico
Prior art keywords
disease
pharmaceutical composition
patient
preventing
treating
Prior art date
Application number
MX2012012712A
Other languages
Spanish (es)
Other versions
MX341960B (en
Inventor
Peter Sondermann
Peter Buckel
Sascha Tillmanns
Ingrid Berger
Original Assignee
Suppremol Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suppremol Gmbh filed Critical Suppremol Gmbh
Priority to MX2012012712A priority Critical patent/MX341960B/en
Publication of MX2012012712A publication Critical patent/MX2012012712A/en
Publication of MX341960B publication Critical patent/MX341960B/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to a method for treating or preventing either one or both of an inflammatory disease and an autoimmune disease in a patient, wherein the method comprises providing a pharmaceutical composition containing a therapeutically effective amount of soluble Fc.gamma.R; administering said composition to a patient, followed by a safety period of several weeks, followed by a subsequent treatment cycle of at least two weekly administrations, wherein said therapeutically effective amount is effective to treat or prevent said disease in said patient. Further to a pharmaceutical composition in the form of a multiple-dosage-kit which contains sufficient amounts of administration doses of soluble Fc.gamma.R for effectively treating or preventing inflammatory diseases and/or autoimmune diseases in a patient.
MX2012012712A 2012-10-31 2012-10-31 A pharmaceutical composition for use in treating or preventing either one or both of an inflammatory disease and an autoimmune disease. MX341960B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2012012712A MX341960B (en) 2012-10-31 2012-10-31 A pharmaceutical composition for use in treating or preventing either one or both of an inflammatory disease and an autoimmune disease.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2012012712A MX341960B (en) 2012-10-31 2012-10-31 A pharmaceutical composition for use in treating or preventing either one or both of an inflammatory disease and an autoimmune disease.

Publications (2)

Publication Number Publication Date
MX2012012712A true MX2012012712A (en) 2014-04-30
MX341960B MX341960B (en) 2016-09-08

Family

ID=51213278

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012012712A MX341960B (en) 2012-10-31 2012-10-31 A pharmaceutical composition for use in treating or preventing either one or both of an inflammatory disease and an autoimmune disease.

Country Status (1)

Country Link
MX (1) MX341960B (en)

Also Published As

Publication number Publication date
MX341960B (en) 2016-09-08

Similar Documents

Publication Publication Date Title
NZ725006A (en) Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the cns
MX2022013172A (en) Use of a pcsk9 inhibitor to treat hyperlipidemia.
JO3784B1 (en) Combined use of anti pd-1 and anti m-csf antibodies in the treatment of cancer
EA201270221A1 (en) TREATMENT OF CROWN DISEASE WITH LACQUINIMODE
EA201490377A1 (en) TREATMENT OF MULTIPLE SCLEROSIS BY COMBINATION OF LAKVINIMODE AND GLATIRAMER ACETATE
ECSP14012676A (en) CARBAMATE COMPOUNDS AND THE PREPARATION AND USE OF THEM
MX2019012884A (en) Combination therapy.
BR112015010396A2 (en) combination therapy
NZ703940A (en) Pharmaceutical combinations comprising a b-raf inhibitor, an egfr inhibitor and optionally a pi3k-alpha inhibitor
MX2014002171A (en) Combination treatments for hepatitis c.
WO2015085143A3 (en) Therapeutic agents for skin diseases and conditions
WO2016090024A3 (en) Combination therapy for treatment of cancer
WO2012079093A3 (en) Dosage and administration of bispecific scfv conjugates
MX2018013715A (en) Aqueous based capsaicinoid formulations, and treatment in combination with a corticosteroid.
MX2016006179A (en) Aqueous based capsaicinoid formulations and methods of manufacture and use.
WO2012142615A3 (en) Auranofin and auranofin analogs useful to treat proliferative disease and disorders
EA201370230A1 (en) NEW ROCK INHIBITORS
EA201490516A1 (en) BIFENILKARBOXYAMIDES AS ROCK KINAZ INHIBITORS
MX2015016418A (en) Dihydroetorphine for the provision of pain relief and anaesthesia.
TW201129361A (en) Methods for treating pain
MX2012012712A (en) A pharmaceutical composition for use in treating or preventing either one or both of an inflammatory disease and an autoimmune disease.
PH12015502465A1 (en) Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias
MX358512B (en) Methods of maintaining, treating or improving cognitive function.
TW201613599A (en) Use of composition for manufacture of medicament for suppressing androgen receptor related function and treatment of androgen receptor related disease
WO2013181217A3 (en) Novel compounds and compositions for treatment of breathing control disorders or diseases

Legal Events

Date Code Title Description
FG Grant or registration